Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Gistrup

36 clinical trials in Gistrup, Denmark. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Gistrup at a glance
36
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

36 trials in Gistrup

Open in trial search
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Elafibranor
  • Sponsor:Ipsen Bioscience Inc.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Methylprednisolone
  • Sponsor:Region Hovedstaden
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:AZD5148
  • Sponsor:AstraZeneca AB

Other cities in Denmark

The busiest research cities in the country

All 47 cities in Denmark

Clinical research in Gistrup

What the registry says about research in the country

01 Cardiovascular Research

Innovative research focusing on heart failure prevention through combination therapy studies. Clinical trials are evaluating the effectiveness of baxdrostat in combination with dapagliflozin for reducing cardiovascular mortality risk.

  • Heart Failure Prevention
  • Cardiovascular Death Risk Reduction
  • Combination Therapy Assessment

These studies aim to advance treatment options for patients at elevated risk of developing heart failure.

02 Nephrology and Diabetes

Groundbreaking research investigating chronic kidney disease management in patients with type 1 diabetes. Studies are examining the efficacy of finerenone as an addition to standard care treatment protocols.

  • Diabetic Kidney Disease
  • UACR Reduction
  • Renal Function Improvement

This research focuses on developing enhanced therapeutic approaches for complex diabetic kidney complications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.